CARE Pharmacies and Leading Edge Pharms to Expand Access to Opioid Alternatives for Pain Management

HENDERSON, Nevada, December 17, 2018 /PRNewswire/ --

CARE Pharmacies Cooperative Inc. (CARE), a growing independent retail drug chain serving local communities throughout the United States, and Leading Edge Pharms, Inc. (Leading Edge), a biotechnology company developing novel cannabinoid therapies and innovative delivery platforms, announced today a preferred provider relationship for Leading Edge to provide CANNAVERA™ Topical Pain Relief products to CARE Pharmacies Member Pharmacies.

"CARE Pharmacies has been a trusted source of medications for over 60 years. Our new partnership with Leading Edge demonstrates our unwavering commitment to delivering better medicine to more people," said Mark Ey, Vice President of Operations for CARE Pharmacies. "Leading Edge's CANNAVERA Topical Pain Relief series can be an effective and natural first step in pain management. We are proud to offer these products to our member pharmacies, which can significantly improve the quality of life of those managing chronic pain."

Through this preferred relationship, CARE Pharmacies will offer CANNAVERA products at over 100 locations in 22 states to patients from hospitals, physical rehabilitation centers and pain clinics. All CANNAVERA products are manufactured at an FDA-registered laboratory and follow current Good Manufacturing Practices (cGMP).

"This new partnership provides CANNAVERA consumers with a simple, secure and convenient purchase option," said David Chadwick, CEO of Leading Edge Pharms. "We share a mutual commitment with CARE Pharmacies: providing quality non-opioid solutions for pain management. We strive to provide the very best cannabinoid therapies through innovative delivery systems that are natural, safe and effective in order to address the unacceptable harmful side-effects attributed to the use of opioid drugs. Our partnership with CARE will play an important role in helping us achieve that vision."

ABOUT CARE PHARMACIES COOPERATIVE INC. 
CARE Pharmacies is a member-owned cooperative of independent community retail and specialty pharmacies, offering a full range of programs and services designed to meet the dynamic needs of the independent pharmacy owner operator. Recognized by the National Retail Federation as one of the fastest growing retailers in the country, CARE has over 100 locations in 22 states including the District of Columbia. CARE's mission is a promise to its members to represent their interests, support their growth, and enable them to provide superior patient satisfaction. CARE does this to enhance the success of its member pharmacies; as well as, to ensure the future of community pharmacy. For more information, contact CARE at 866.CARE.RXS, or to locate a CARE Pharmacy near you, visit http://www.carepharmacies.com.

ABOUT LEADING EDGE PHARMS, INC. 
Leading Edge Pharms, Inc. (LEP) is a biotechnology company focused on the research, development and commercialization of novel cannabinoid therapies and innovative delivery platforms. LENCURA LABS™ is LEP's Research & Innovation Division that specializes in formulating pharmaceutical grade cannabinoid compounds designed for clinical use, then further developed as natural consumer healthcare products. LEP's first commercial product is Silvidiol™, a proprietary compound formulated with THC-Free Broad-Spectrum Organic CO₂ Hemp extract and Emerald Aloe Vera. Silvidiol™ is nano-encapsulated in LEP's proprietary Silvasome™ Delivery System used in manufacturing the CANNAVERA™ product line, available at http://www.LENCURA.com in topical oil, crème, ointment and liquid forms. CANNAVERA™ products are natural, non-systemic, THC Free and marketed as a step-wise approach to pain management therapy in the Opioid-Alternative category.

Leading Edge Pharms Company Contact:  
David Chadwick, CEO
[email protected] 
+1-(800)-813-0013

Leading Edge Pharms Media Contact 
Nicole Grubner
[email protected] 
+1-(929)-222-8011

SOURCE Leading Edge Pharms and CARE Pharmacies